REUTERS: Men who show signs that their disease has returned after prostate cancer treatment are still more likely to die of other causes, a new study in US veterans shows. READ MORE>
Posts Tagged ‘Biochemical recurrence’
Most men whose prostate cancer recurs still survive
Posted in Biochemical recurrence, tagged Biochemical recurrence, cancer research, catheter, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate recurs, prostate survival, REUTERS, US veterans on August 29, 2010 | Leave a Comment »
Bigger the prostate tumour removed, greater the risk of recurrence
Posted in Biochemical recurrence, tagged Biochemical recurrence, cancer research, catheter, prostablog, prostate, prostate blog, PROSTATE CANCER, Radical prostatectomy, tumour size on July 9, 2010 | Leave a Comment »
URO TODAY: The size of your prostate tumour may predict whether you’ll get a recurrence of the disease after a prostatectomy – the bigger the tumour, the more the risk. READ MORE>
Active surveillance may not be wise choice for younger men with low risk prostate cancer
Posted in Biochemical recurrence, PROSTATE CANCER, PROSTATE RESEARCH, Watchful waiting, tagged "long" life expectancies, active surveillance, Biochemical recurrence, cancer research, catheter, comparison of treatments, low-risk disease, low-risk prostate cancer, prostablog, prostate, prostate blog, prostate cancer treatments, prostate treatment debate, URO TODAY, Watchful waiting on June 20, 2010 | Leave a Comment »
URO TODAY: Watchful waiting may not be a wise choice for younger men diagnosed with low risk prostate cancer, a new study suggests.
Our pathologic findings and risk of biochemical recurrence after open radical prostatectomy question the wisdom of active surveillance in men with low-risk disease who have “long” life expectancies. READ MORE>
Prostate cancer prognosis changes if PSA starts to rise again after treatment
Posted in Biochemical recurrence, PROSTATE CANCER, PROSTATE RESEARCH, PSA tests, tagged Australasian researchers, Biochemical recurrence, cancer research, catheter, initial prostate cancer treatment, Low initial PSA, Professor David Lamb, prognostic factors for survival, prostablog, prostate, prostate blog, PROSTATE CANCER, PUB MED.COM, rapid PSA doubling time, short time to biochemical recurrence, URO TODAY on October 22, 2009 | Leave a Comment »
PUB MED.COM: When biochemical recurrence occurs after initial prostate cancer treatment, prognostic factors for survival change, according to a new report from Australasian researchers (including NZ’s Professor David Lamb) who investigated at NZ and Australian patients. READ MORE>
Low initial PSA, short time to biochemical recurrence, and rapid PSA doubling time take over at this point, providing reasons why initial PSA and occurrence of biochemical recurrence alone predict prostate cancer-specific survival poorly.
Researchers find out prostate cancer survival chances change if biochemical recurrence occurs
Posted in Biochemical recurrence, PROSTATE CANCER, PROSTATE RESEARCH, PSA tests, tagged Biochemical recurrence, cancer research, likelihood of surviving prostate cancer, low PSA, outlook, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate treatment, prostate treatment debate, prostate-specific antigen, PSA, PSA doubling time, PSA test, time to recurrence, URO TODAY on September 26, 2009 | Leave a Comment »
URO TODAY: Factors used to predict a man’s likelihood of surviving prostate cancer change significantly if biochemical recurrence occurs – and his outlook is less favourable if he had low PSA when initially diagnosed, the time to recurrence is short and PSA doubling time is rapid. READ MORE>
New DNA vaccine shown to slow PSA doubling in trial on prostate cancer patients
Posted in Biochemical recurrence, New prostate drugs, PROSTATE CANCER, PROSTATE RESEARCH, PSA tests, tagged advanced prostate cancer, Biochemical recurrence, cancer research, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate DNA vaccine, prostate treatment, prostate-specific antigen, PSA, PSA doubling, PSA test, URO TODAY on September 4, 2009 | Leave a Comment »
URO TODAY: US scientists have successfully tested a new DNA vaccine that significantly slows PSA doubling, the signal of a belated return of prostate cancer after treatment. READ MORE>
Size doesn’t matter – in case of recovery from radical prostatectomy
Posted in Biochemical recurrence, PROSTATE CANCER, PROSTATE RESEARCH, Radical prostatectomy, tagged Biochemical recurrence, blood loss, cancer research, Enlarged prostate, larger prostate size, operaion time, positive surgical margins, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate size, prostate treatment, prostatectomy, Radical prostatectomy, smaller glands, surgery, URO TODAY on August 27, 2009 | Leave a Comment »
URO TODAY: Prostate size does not appear to affect biochemical recurrence after radical prostatectomy. However, estimated blood loss and operation time increased with larger prostate size, and positive surgical margins are more often observed in smaller glands. READ MORE>









